Works matching IS 02724391 AND DT 2021 AND VI 82 AND IP 3
Results: 15
Design of multicomponent indomethacin‐paracetamol and famotidine loaded nanoparticles for sustained and effective anti‐inflammatory therapy.
- Published in:
- Drug Development Research, 2021, v. 82, n. 3, p. 448, doi. 10.1002/ddr.21768
- By:
- Publication type:
- Article
TWIRLS, a knowledge‐mining technology, suggests a possible mechanism for the pathological changes in the human host after coronavirus infection via ACE2.
- Published in:
- Drug Development Research, 2021, v. 82, n. 3, p. 465, doi. 10.1002/ddr.21817
- Publication type:
- Article
Calcium sensing receptor as a novel target for treatment of sepsis induced cardio‐renal syndrome: Need for exploring mechanisms.
- Published in:
- Drug Development Research, 2021, v. 82, n. 3, p. 305, doi. 10.1002/ddr.21797
- By:
- Publication type:
- Article
N‐(3′,4′‐dimethoxycinnamonyl) anthranilic acid alleviates severe acute pancreatitis by inhibiting intestinal barrier dysfunction and NF‐κB activation.
- Published in:
- Drug Development Research, 2021, v. 82, n. 3, p. 458, doi. 10.1002/ddr.21769
- By:
- Publication type:
- Article
Synergistic interaction between B vitamins and statins to counter nociception in rats.
- Published in:
- Drug Development Research, 2021, v. 82, n. 3, p. 440, doi. 10.1002/ddr.21767
- By:
- Publication type:
- Article
Combination of canstatin and arsenic trioxide suppresses the development of hepatocellular carcinoma.
- Published in:
- Drug Development Research, 2021, v. 82, n. 3, p. 430, doi. 10.1002/ddr.21766
- By:
- Publication type:
- Article
Proteolysis targeting chimera (PROTAC) for epidermal growth factor receptor enhances anti‐tumor immunity in non‐small cell lung cancer.
- Published in:
- Drug Development Research, 2021, v. 82, n. 3, p. 422, doi. 10.1002/ddr.21765
- By:
- Publication type:
- Article
Fenofibrate attenuates ischemia reperfusion‐induced acute kidney injury and associated liver dysfunction in rats.
- Published in:
- Drug Development Research, 2021, v. 82, n. 3, p. 412, doi. 10.1002/ddr.21764
- By:
- Publication type:
- Article
Paeoniflorin inhibited nod‐like receptor protein‐3 inflammasome and NF‐κB‐mediated inflammatory reactions in diabetic foot ulcer by inhibiting the chemokine receptor CXCR2.
- Published in:
- Drug Development Research, 2021, v. 82, n. 3, p. 404, doi. 10.1002/ddr.21763
- By:
- Publication type:
- Article
Barbiturate derivatives for managing multifaceted oncogenic pathways: A mini review.
- Published in:
- Drug Development Research, 2021, v. 82, n. 3, p. 364, doi. 10.1002/ddr.21761
- By:
- Publication type:
- Article
Role of mineralocorticoid receptor antagonists in kidney diseases.
- Published in:
- Drug Development Research, 2021, v. 82, n. 3, p. 341, doi. 10.1002/ddr.21760
- By:
- Publication type:
- Article
Ameliorative effect of a nano chromium metal–organic framework on experimental diabetic chronic kidney disease.
- Published in:
- Drug Development Research, 2021, v. 82, n. 3, p. 393, doi. 10.1002/ddr.21759
- By:
- Publication type:
- Article
Surface receptor‐mediated targeted drug delivery systems for enhanced cancer treatment: A state‐of‐the‐art review.
- Published in:
- Drug Development Research, 2021, v. 82, n. 3, p. 309, doi. 10.1002/ddr.21758
- By:
- Publication type:
- Article
Step toward repurposing drug discovery for COVID‐19 therapeutics through in silico approach.
- Published in:
- Drug Development Research, 2021, v. 82, n. 3, p. 374, doi. 10.1002/ddr.21757
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Drug Development Research, 2021, v. 82, n. 3, p. 303, doi. 10.1002/ddr.21692
- Publication type:
- Article